1. Home
  2. COHR vs VTRS Comparison

COHR vs VTRS Comparison

Compare COHR & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHR
  • VTRS
  • Stock Information
  • Founded
  • COHR 1971
  • VTRS 1961
  • Country
  • COHR United States
  • VTRS United States
  • Employees
  • COHR N/A
  • VTRS N/A
  • Industry
  • COHR Electronic Components
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • COHR Technology
  • VTRS Health Care
  • Exchange
  • COHR Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • COHR 9.8B
  • VTRS 9.0B
  • IPO Year
  • COHR 1987
  • VTRS N/A
  • Fundamental
  • Price
  • COHR $70.56
  • VTRS $8.77
  • Analyst Decision
  • COHR Strong Buy
  • VTRS Hold
  • Analyst Count
  • COHR 16
  • VTRS 4
  • Target Price
  • COHR $104.19
  • VTRS $10.50
  • AVG Volume (30 Days)
  • COHR 3.2M
  • VTRS 13.4M
  • Earning Date
  • COHR 05-07-2025
  • VTRS 05-08-2025
  • Dividend Yield
  • COHR N/A
  • VTRS 5.41%
  • EPS Growth
  • COHR N/A
  • VTRS N/A
  • EPS
  • COHR N/A
  • VTRS N/A
  • Revenue
  • COHR $5,595,041,000.00
  • VTRS $14,330,200,000.00
  • Revenue This Year
  • COHR $23.39
  • VTRS N/A
  • Revenue Next Year
  • COHR $9.98
  • VTRS $1.20
  • P/E Ratio
  • COHR N/A
  • VTRS N/A
  • Revenue Growth
  • COHR 21.67
  • VTRS N/A
  • 52 Week Low
  • COHR $45.58
  • VTRS $6.85
  • 52 Week High
  • COHR $113.60
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • COHR 59.78
  • VTRS 57.48
  • Support Level
  • COHR $66.71
  • VTRS $8.47
  • Resistance Level
  • COHR $73.05
  • VTRS $9.57
  • Average True Range (ATR)
  • COHR 3.27
  • VTRS 0.30
  • MACD
  • COHR 1.36
  • VTRS 0.15
  • Stochastic Oscillator
  • COHR 86.60
  • VTRS 59.39

About COHR Coherent Corp.

Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: